12th Annual Outsourcing in Clinical Trials UK & Ireland 2025

Welcome to 12th annual Outsourcing in Clinical Trials UK and Ireland 2025

10 - 11

June

2025
  • Hilton Park Lane, London, UK
  • Complimentary
  • Why attend?
  • Agenda
  • Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • 2025 Sponsors
  • Media Centre
  • Why partner?
  • Resources
  • Contact Us
close

Sponsors Include:

Back

Company Information

EMIS Recruit is an integrated solution that connects Research, Life Sciences and healthcare by embedding clinical research recruitment tools directly into the point of care systems.  EMIS recruit gives research organisations clear visibility of clinically relevant patients based on your study protocol. This enables us to provide you with qualified patients that streamline your recruitment process

Next Sponsor
Back

Company Information

Simply sourcing comparators – we offer a unique blend of small company flexibility and speed, backed with the large-scale buying power of the Orifarm Group, which is one of the largest pharmaceutical suppliers in Europe. With over €1.4B products sold in 2021 and more than 4,000 unique product lines sourced on a monthly basis, we have unparalleled access to “out of market” and manufacturer direct buying capability, both in the US and Europe.

Company website: www.Orifarm-CTS.com

Company Website

To learn more, please visit our website - www.Orifarm-CTS.com

Next Sponsor
Back

Company Information

Imagine a paediatric-specific engagement platform, fully co-designed with children and child life specialists. The Little Journey app helps to reduce anxiety before, during and after paediatric clinical trial visits by educating and preparing children and families using engaging, age-tailored personalised multimedia that can be accessed anywhere at any time.

Company Website

To learn more, please visit our website - https://www.littlejourney.health/

Next Sponsor
Back

Company Information

Cytel Inc. www.cytel.com is a leading provider of clinical research services and trial design and analysis software primarily for the biopharmaceutical and medical device development markets.

Cytel pioneered the statistical and computational science of adaptive clinical trials and has designed more validated adaptive trials than any other service provider.

Company Website

To learn more, please visit our website - http://www.cytel.com

Next Sponsor
Back

Company Information

Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com. 

Company Website

To learn more, please visit our website - www.SyneosHealth.com

Next Sponsor
Back

Company Information

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 35,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

Company Website

To learn more, please visit our website - https://www.medidata.com

Next Sponsor
Back

Company Information

Founded in 2015 Teckro provides solutions to simplify and modernize clinical research for leading pharmaceutical and emerging biotech companies. To date, Teckro manages more than 100 clinical trials and is used by more than 11,800 active study sites around the world. Teckro employs more than 100 staff across its global headquarters in Limerick, Ireland, engineering excellence hub in Dublin, Ireland and its US-based office in Nashville, Tennessee. Visit www.teckro.com for more information.

 

Company Website

To learn more, please visit our website - http://www.teckro.com/

Next Sponsor
Back

Company Information

Medicover Integrated Clinical Services is a unique clinical research organization with 25 years of experience.

We offer Patient Recruitment services through our own Clinical Research Network in Central and Eastern Europe with comprehensive Global Central Lab Services and access to over 8,000 tests from routine to advanced diagnostics including genetics, biomarkers, PK and PD, and PBMC isolation in more than 120 laboratories in Europe and India.

Company Website

To learn more, please visit our website - https://medicover-mics.com/

Next Sponsor
Back

Company Information

Optimapharm is a globally operating, leading, mid-sized, full-service CRO aiming to deliver new therapies to improve and save patients’ lives.
With 26 strategically located offices, Optimapharm is giving unrivalled access to Patients and Investigators worldwide.
Optimapharm conducts phase I – IV studies in all therapeutic areas. With very strong operational teams, Optimapharm has a reputation for excellence delivery in all projects, including rescue studies.

Company Website

To learn more, please visit our website - https://optimapharm.eu/

Next Sponsor
Back

Company Information

Greenphire is the industry leader of clinical payment technology, designed to improve the way research professionals work. We leverage our proprietary payments platform and workflow automation to help clients improve operational efficiency, reduce costs, mitigate regulatory risks, improve the patient and site experience and produce quantifiable results that improve clinical operations and strategic planning.

Company Website

To learn more, please visit our website - http://greenphire.com/

Next Sponsor
Back

Company Information

ESMS Global provides specialist support related to Clinical Trials and Medical Information. Our services include a Global Emergency Unblinding Service, Clinical Trials Direct to Patient Helpline, Serious Breach Reporting Service, and a Medical Information Helpline, all available 24/7, across the globe, in 45 languages.

Company Website

To learn more, please visit our website - www.esmsglobal.com

Next Sponsor
Back

Company Information

At Trilogy, medical writing is our passion. As specialists in clinical regulatory documentation, we provide a service that is more than just writing. We proactively plan, coordinate and write clinical documents to meet timelines, with a readability that reduces the time for review and approval.

Company Website

To learn more, please visit our website - https://www.trilogywriting.com/

Next Sponsor
Back

Company Information

TFS HealthScience is a global Contract Research Organization (CRO) partnering with biotechnology and pharmaceutical companies throughout their entire clinical development journey. Bringing together nearly 700 professionals, we deliver tailored clinical research services in more than 40 countries. TFS supports customers with comprehensive solutions including full clinical development services, strategic and flexible resourcing. In partnership, we build solution-driven teams of experienced professionals working together for a healthier future. Our mission is to bring treatments to patients faster. For more information, please visit www.tfscro.com.

Company Website

To learn more, please visit our website - www.tfscro.com.

Next Sponsor
Back

Company Website

To learn more, please visit our website - http://www.medpace.com/

Next Sponsor
Back

Company Information

The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 18 facilities including Europe, the US and Asia.

The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

To keep up to date with latest news, follow Almac Group on Twitter and LinkedIn or visit almacgroup.com.

Company Website

To learn more, please visit our website - https://www.almacgroup.com

Next Sponsor
Back

Company Information

At Viedoc, we design engaging software that modernizes clinical research so that necessary treatments can reach the people who need them faster. We believe in life and science, in people, and in our collective power to change the world and build a healthier future. That unmatched driving force is what pushes us to innovate, accelerate and improve every aspect of modern clinical studies.

Company Website

To learn more, please visit our website - www.viedoc.com

Next Sponsor
Back

Company Information

Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries.

Company Website

To learn more, please visit our website - https://www.suvoda.com/

Next Sponsor
Back

Company Information

ClinChoice is a leading full-service clinical CRO offering high-quality solutions to pharmaceutical, biotechnology, medical device and consumer products clients. We contribute to a safer and better world by helping our sponsor clients accelerate drug and device approvals to market. We do this by combining our 25 years of proven quality and results with expertise in 30+ therapeutic areas, a flexible approach, and dedicated teams who enable rapid startups and fast timelines.

Next Sponsor
Back

Company Information

CMIC Group, founded as Japan’s first CRO over 30 years ago, is now the largest clinical CRO in Japan with a global presence. Our services span non-clinical studies, clinical trial management, GMP manufacturing, regulatory consulting, and sales/marketing solutions. We facilitate market entry in Japan, offer leading clinical trial expertise in APAC region, and bridge drug development between the US and Japan. With 7,000+ employees and 24 global sites, we’re your comprehensive partner in the pharmaceutical, biotech, and medical device sectors.

Company Website

To learn more, please visit our website - https://en.cmicgroup.com/

Next Sponsor
Back

Company Information

B. Braun specialises in manufacturing market leading infusion therapy products, many of which are supplied into clinical trials. With presence in over 64 countries around the world, we work closely with our partners to select solutions that fit with the individual clinical trial requirements.

For more information, please visit:

Company Website

To learn more, please visit our website - bbraun.co.uk/en/products-and-therapies/bbraun-industrial-business.html

Next Sponsor

    Why attend?

    We are delighted to welcome you to 12th annual Outsourcing in Clinical Trials UK and Ireland.

    This is a great opportunity to get together and network face to face, hear from our expert speaker line-up and discuss the latest innovations and regulatory updates in the industry.

    This exclusive event brings together attendees from established pharma, large and small, alongside biopharmaceutical companies and gives opportunity to dive into the operational challenges and innovations in clinical development found within the UK & Ireland region.

    This year will also focus on government initiatives for UK growth and opportunities within the clinical trial landscape.

    We look forward to you joining us!

     

    WHAT TO EXPECT FOR 2025?

    This exclusive event brings together attendees from established pharma, large and small, alongside with biopharmaceutical companies and gives opportunity to dive into the operational challenges and innovations in clinical development found within the UK & Ireland region.

    200+

    Attendees

    		50+

    Exhibitors

    		40+

    Speakers
    200+

    Attendees

    		50+

    Exhibitors
    40+

    Speakers

    Testimonials

    See What It's All About

    Agenda

    • 10 Jun 2025
    • 11 Jun 2025
    Expand All

    Streams

    Stream one

    STREAM A: UK Clinical Trial Landscape Strategy

    Stream two

    STREAM B: Clinical Technology and Innovation

    Stream three

    STREAM C: Clinical Trials in Oncology

    10 AM

    PANEL DISCUSSION: Exploring the landscape for oncology clinical trials in the UK

    • New regulations and guidance around running oncology trials in the UK: what do you need to be aware of?
    • Running clinical trials in conjunction with the NHS: how to ensure your trial is a success
    • Developments in UK cancer research: what’s new in 2025?
    • Working with patients and advocacy groups in the UK: keeping patients at the heart of your oncology trials
    • Assessing the impact of political and economic changes on UK oncology trials
    • The role of the cancer drug fund in accelerating oncology clinical trials in the UK

     

    MODERATOR:

    Richard Stephens, Chair, Cancer Research Advocates Forum (CRAF-UK)

    PANELLISTS:

    Emily Pegg, Associate Vice President, Medical, Northern European Hub, Eli Lilly

    Further panellists to be confirmed

    Speakers

    Richard Stephens
    Chair, Cancer Research Advocates Forum (CRAF-UK)
    Emily Pegg
    Associate Vice President, Medical, Northern European Hub, Eli Lilly

    10:45 AM

    PATIENT STORY: Positive and negative experiences in a patient’s cancer journey: how should clinicians and patients work together?

    Speakers

    Maria Lawal
    Patient Advocate

    11:15 AM

    Morning refreshments and networking

    11:45 AM

    Reserved for

    Speakers

    Stephen Nabarro
    Head of Clinical Operations and Data Management, Cancer Research UK

    12:15 PM

    Available for event sponsor

    12:45 PM

    CASE STUDY: Conducting a Phase 2 oncology trial in the UK

    Speakers

    Diane Chisholm
    Head of Clinical Operations, Owkin

    1:15 PM

    Lunch and networking

    2:15 PM

    PANEL DISCUSSION: Patient centricity in oncology trials: where are the opportunities for the industry and patients?

    • Simple ways of improving patient experience in clinical trials including vocabulary and clear communication
    • Relieving burden on caregivers as well as patients: how can sponsors be more supportive of patients’ families and support network?
    • Working with patients from the beginning of your clinical trial design process
    • Assessing new innovation and technology which can increase support and relieve pressure on oncology patients
    • Where and how can trial sponsors step in to provide long term support for rare cancer patients?
    MODERATOR:

    Richard Stephens, Chair, Cancer Research Advocates Forum (CRAF-UK)

    Speakers

    Richard Stephens
    Chair, Cancer Research Advocates Forum (CRAF-UK)
    Diane Chisholm
    Head of Clinical Operations, Owkin
    Liz Emmerson
    Director Clinical Operations, Blue Earth Therapeutics

    3 PM

    Available for event sponsor

    3:30 PM

    Afternoon refreshments and networking

    4 PM

    Navigating complexities of managing radioligand therapy oncology trials

    • Site selection considerations specific to Radiopharmaceutical Therapy (RPT) clinical trials
    • A sponsor’s perspective of the technical knowledge and expertise required to deliver RPT studies
    • Country specific RPT clinical trial requirements and regulations
    • Challenges with just-in-time supply for RPT investigational products

    Speakers

    Liz Emmerson
    Director Clinical Operations, Blue Earth Therapeutics

    4:30 PM

    Delivering research in NHS hospitals: the new NIHR Research Delivery Network (RDN)

    • The new NIHR RDN landscape
    • Delivering research in hospital settings
    • Research delivery in partnership

    Speakers

    Prof Sandip Mitra
    NIHR National Lead for Research in NHS Hospital Setting, Deputy Director for NIHR Health Technology Centre for Long Term Conditions (D4D), National Institute for Health and Care Research (NIHR)

    5 PM

    Chairperson’s closing remarks

    Speakers

    Richard Stephens
    Chair, Cancer Research Advocates Forum (CRAF-UK)

    11:45 AM

    Optimising patient consent and data management in a shifting geopolitical landscape

    This session explores the evolving role of patient consent in clinical trials, focusing on how to maximize its value while ensuring ethical and regulatory compliance. As geopolitical and regulatory landscapes shift, the management of patient samples and data has become increasingly complex. Industry experts will discuss strategies for streamlining consent processes, enhancing transparency, and addressing the challenges of cross-border data and sample handling.

    • The changing nature of patient consent
    • Geopolitical and regulatory impacts on data management
    • Innovative approaches to sample and data tracking
    • Future trends in patient consent and data usage

    Speakers

    Catherine Mela
    Head Precision Medicine Operations, GSK

    12:15 PM

    Available for event sponsor

    12:45 PM

    Holding session:

    Leveraging novel technologies, digital advances and strategic transformation to accelerate clinical trials, in turn, optimising operational process and elevate the patient experience.

    Speakers

    Rebecca Jackson
    Associate Director, Global Development Systems, Janssen

    1:15 PM

    Lunch and networking

    2:15 PM

    PANEL DISCUSSION: Leveraging technology and innovation to support clinical trial execution

    • Adopting innovative technologies to improve clinical trial efficiency
    • Transforming clinical trials using AI driven data analysis
    • Identifying digital tools for patient engagement

     

    MODERATOR:

    Moderator to be confirmed

     

    Speakers

    Lara Campana
    Senior Vice President, Research and Translational Science, Resolution Therapeutics
    Blanka Hezelova
    Associate Director, Precision Medicine Scientific Operations, Bioethics Coach, GSK
    Joseph Sutton
    PhD, Biosample Project Leader and Senior Scientist, Roche

    3 PM

    Available for event sponsor

    3:30 PM

    Afternoon refreshments and networking

    4 PM

    SUSTAINABILITY SPOTLIGHT: Inspiring partnerships and action in sustainable healthcare

    Mitigating the environmental impact of clinical trials, in line with the broader imperative to address the interconnected climate and health crises.

    Speakers

    Dr Fiona Adshead
    Chair, Sustainable Healthcare Coalition
    Pete Morley
    Clinical Sustainability Manager, Novo Nordisk

    4:30 PM

    CASE STUDY: Abbreviated clinical trials: driving innovation and expediting development

    Innovation to reduce the reliance on the global cold chain

    Speakers

    Karen O’Hanlon
    Chief Development Officer, Stablepharma

    5 PM

    Chairperson’s closing remarks

    8 AM

    Registration and refreshments

    8:45 AM

    GlobalData opening remarks

    Senior representative, GlobalData

    9 AM

    OPENING KEYNOTE: Clinical trials in the UK: a cross sector approach to making the UK a destination for clinical research

    • Government priorities: one year on
    • How organisations across the sector are working together to continually improve the system
    • What makes the UK a destination for clinical trials
    • Looking ahead

    Speakers

    Prof. Lucy Chappell
    Chief Scientific Adviser, Department of Health and Social Care, Chief Executive Officer, National Institute of Health Research (NIHR)

    9:30 AM

    Reserved for event sponsor

    10 AM

    KEYNOTE PANEL: Where is the clinical trial industry headed this year and beyond?

    • Navigating new regulations around clinical trials smoothly and successfully
    • How do we ensure the UK is an attractive location to run ATMP trials
    • The impact of artificial intelligence: how far can we expect to move forward in the next 12 months?
    • Patient centricity in clinical trials: how can burden be reduced in order to make trials easier for patients to participate in?
    • Technological developments in 2025 and beyond: what changes can we expect to see in the next 3-5 years?

     

    MODERATOR:

    Moderator to be confirmed

     

    PANELLISTS:

    Alex Churchill, Deputy Director, Clinical Trials Policy, Department of Health and Social Care

    Esther Kitto, Vice President, Clinical Operations, Resolution Therapeutics

    Speakers

    Alex Churchill
    Deputy Director, Clinical Trials Policy, Department of Health and Social Care
    Esther Kitto
    Vice President, Clinical Operations, Resolution Therapeutics

    10:45 AM

    Reserved for event sponsor

    11:15 AM

    Morning refreshments and networking

    11:45 AM

    MHRA: The new outlook of the Clinical Trials Unit

    • Activities
    • Innovations
    • International collaborations

    Speakers

    Andrea Manfrin
    Deputy Director, Clinical Investigations and Trials, MHRA

    12:15 PM

    Available for event sponsor

    12:45 PM

    How can we all maximise the efficiency of study set-up?

    • Learn opportunities for navigating ethics and regulatory reviews quickly
    • Discover the ideal path through study set-up
    • Help NHS sites to follow national standards
    • Explore new UK clinical trials regulations

    Speakers

    Dr Janet Messer
    Director of Approvals, HRA

    1:15 PM

    Lunch and networking

    2:15 PM

    PANEL DISCUSSION: Partnering for innovation: a new model to deliver commercial clinical trials at pace and scale

    • The Vaccine Innovation Pathway: delivering results and shaping the future
    • Real-world innovations in site-level delivery
    • Reimagining clinical research delivery: innovative models and collaborative approaches
    • Expanding primary care horizons: commercial trials in the community
    • Driving innovation from industry: lessons learned and future directions

    MODERATOR:

    Moderator to be confirmed

    Speakers

    Maria Koufali
    Head of UK Vaccine Innovation Pathway, National Institute for Health and Care Research (NIHR)
    Sarah Tissington
    Regional Director, Clinical Site Management & Monitoring EU/UK, Moderna
    Prof Saul Faust
    OBE, Director, NIHR Southampton Clinical Research Facility, University of Southampton; Clinical Director, NIHR LCRN Wessex
    Dr Rebecca Clark
    , Partner, Principal Investigator, Fylde Coast Clinical Research and Co-Clinical Lead, UK Vaccine Innovation Pathway

    3 PM

    Available for event sponsor

    3:30 PM

    Afternoon refreshments and networking

    4 PM

    SPONSOR AND SITE RELATIONSHIPS: Excellence in commercial research delivery: the London North West way

    • Overview of geographic, demographic and disease prevalence landscape in LNWH, which serves a largely under-served region of the UK
    • Building the research infrastructure
    • Impact case studies reflecting challenges and opportunities they present
    • Industry partner perspective

    Speakers

    Divya Manek
    Director, Clinical Operations, Eyebiotech
    Christiana Dinah
    Director, Research and Development, London North West Healthcare NHS Trust

    4:30 PM

    PANEL DISCUSSION: Unravelling the impact of ICH E6 Revision 3: implementing new standards in good clinical practice

    ICH E6 (R3) introduces significant updates to Good Clinical Practice guidelines, emphasizing risk-based quality management, patient centricity, and flexibility in trial design and execution. This panel discussion will address the impact of ICH E6 (R3) on clinical trials, comparing it to the previous ICH E6 (R2), discussing approaches to implementation, and considering varied interpretations among stakeholders.

    • Understand the key changes in ICH E6 (R3) and their implications for clinical trial conduct
    • Explore different approaches to implementing the new guidelines in diverse trial settings
    • Analyse the challenges, opportunities, and interpretations associated with ICH E6 (R3)
    • Highlight meaningful differences between ICH E6 (R2) and ICH E6 (R3) and their practical impacts

    MODERATOR:

    Moderator to be confirmed

     

    PANELLISTS:

    Kerri Fuller, Director, Resp/Imm/ID PM Operations, GSK

    Further panellists to be confirmed

    Speakers

    Kerri Fuller
    Director, Resp/Imm/ID PM Operations, GSK

    5 PM

    Chairperson’s closing remarks

    NETWORKING DRINKS AND APPLE PRIZE DRAW

    Streams

    Stream one

    Clinical Operations and Outsourcing

    Stream two

    Clinical Technology and Innovation

    11:45 AM

    CASE STUDY: Challenges and opportunities in cell therapy clinical development outside oncology

    • Intro into Resolution and our journey from academia to spin out
    • Moving into the clinical space: challenges in developing cell therapy in a space where ATMPs are not widely adopted
    • The role of technology and state-of-the-art analytics to support our cell therapy clinical development

    Speakers

    Lara Campana
    Senior Vice President, Research and Translational Science, Resolution Therapeutics

    12:15 PM

    Available for event sponsor

    12:45 PM

    Lunch and networking

    2 PM

    Clinical trial investigations: looking at the trends and landscape for 2024 and what we can learn from them moving through 2025 and into 2026

    • Overview of global clinical trials for 2024
    • Assessing key sponsors, top interventions and looking at the trial landscape for 2024
    • Looking at key obstacles for terminated trials and evaluation of completed trials which have achieved endpoint status

    Speakers

    Priya Ravisekara
    Senior Analyst, GlobalData

    2:30 PM

    AI in clinical trials: assessing opportunities and challenges in developing an AI strategy

    • How AI and digitalisation can support streamlining of clinical operations and improve efficiency
    • Simple ways to implement tools such as GPT and GenAI in your trial
    • Where can AI be utilized to minimize workloads and increase overall output?
    • The regulatory landscape in the UK for the use of AI in clinical trials: what do you need to know?
    • Key limitations of GenAI and how these impact its potential uses for clinical trials in the UK

    Speakers

    Blanka Hezelova
    Associate Director, Precision Medicine Scientific Operations, Bioethics Coach, GSK

    8 AM

    Registration and refreshments

    8:50 AM

    Chairperson’s opening remarks

    9 AM

    KEYNOTE PRESENTATION: WHO’s clinical trial guidance: what do I need to know

    • Strengthening regulatory and ethical frameworks and ensuring trials follow global standards and Good Clinical Practice
    • Building capacity and infrastructure, training researchers and enhancing facilities for high-quality trial execution
    • Promoting data transparency and global collaboration, registering trials and sharing data to improve research outcomes
    • Streamlining approval processes, speeding up trial initiation for urgent health needs while maintaining safety and compliance

    Speakers

    Vasee Moorthy
    Senior Advisor, R&D, World Health Organization

    9:30 AM

    Available for event sponsor

    10 AM

    The role of R&D in unlocking economic growth and improving population health

    • The investment value of R&D in supporting a geographic spread of research-intensive NHS Trusts
    • The virtuous circle between foreign direct investment, research intensive NHS Trusts and accelerated patient access
    • The role of R&D and research intensive Trusts in re-baselining the standard of care

    Speakers

    Jagtar Dhanda
    Director of Policy Advocacy and Government Affairs, BMS

    10:30 AM

    Available for event sponsor

    11 AM

    Morning refreshments and networking

    11:45 AM

    Patient involvement and engagement, how well are you doing this?

    • Discussing the collaboration that must exist between all parties (patients, coordinators, doctors) in order to have a successful trial
    • Importance of good communication to the patients and how this can streamline trial timelines
    • Exploring how patients could, and should, be influencing decisions and the R&D process before study start-up

    Speakers

    Amelia Hursey
    Strategic Director, Parkinson Europe

    12:15 PM

    Available for event sponsor

    12:45 PM

    Lunch and networking

    2 PM

    Navigating the complexities of running clinical trials both home and away: strategies for success

    • Recruitment strategies: how Lilly selects countries for clinical trials
    • Criteria and processes used by Lilly to recruit and select countries
    • Key factors influencing country selection
    • Performance comparison: UK vs. Other Countries
    • Sharing experiences and lessons from conducting trials in the UK
    • Success stories and challenges faced

    Speakers

    Emily Pegg
    Associate Vice President, Medical, Northern European Hub, Eli Lilly
    Victoria Bhui
    Associate Director, Investigator Engagement, Eli Lilly

    2:30 PM

    PANEL DISCUSSION: Current operational challenges in running commercial clinical trials in the UK/IE: the need for increasing our attractiveness globally

    • Ambition for the UK and the current status
    • Site set up: the need for research ready sites
    • Site recruitment: increasing our say do ratio
    MODERATOR:

    Laura Clifton Hadley, Associate Director, Clinical Operations, BMS

     

    Speakers

    Laura Clifton Hadley
    Associate Director of Clinical Operations, BMS
    Chris Cannaby
    Clinical Operations Manager Lead, MSD
    Saeeda Bashir
    Head, Clinical Trials Policy and Programmes, Department of Health and Social Care
    Esther Kitto
    Vice President, Clinical Operations, Resolution Therapeutics
    Rajinder Sidhu
    Associate Director, Research Governance and Operations, UCLH

    3 PM

    Afternoon refreshments, networking, and Apple Prize Draw

    3:30 PM

    Advancing diversity in clinical research

    • Policy
    • Industry engagement
    • Community engagement
    • Media

    Speakers

    Dr Suki Balendra
    Director, Strategic Partnerships, Paddington Life Sciences and Director, North West London Clinical Trials Alliance

    4 PM

    ROUNDTABLE SESSIONS

    During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table lead/host and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

    ROUNDTABLE 1: TBD

    Kerri Fuller, Director, Resp/Imm/ID PM Operations, GSK

     

    ROUNDTABLE 2: Innovative approaches to support sites facilitate study implementation including EHR data mining, eISF, and SSO login

    Marie Lefebvre, Local Innovation Lead, Sanofi

     

    ROUNDTABLE 3: The role of lived experience in clinical trials: meaningful patient engagement in clinical trials is vital to develop impactful and relevant outcomes

    Cameron Keighron, Project Coordinator, International Diabetes Federation of Europe and Trials@Home consortium member, Patient Advocate

     

     

    Speakers

    Kerri Fuller
    Director, Resp/Imm/ID PM Operations, GSK
    Marie Lefebvre
    Local Innovation Lead, Sanofi
    Cameron Keighron
    Project Coordinator, International Diabetes Federation of Europe and Trials@Home consortium member, Patient Advocate

    5 PM

    Close of conference

    END OF CONFERENCE

    Speakers

    Select a speaker to learn more

    Back
    Liz Emmerson
    Director Clinical Operations, Blue Earth Therapeutics

    Session Details:

    PANEL DISCUSSION: Patient centricity in oncology trials: where are the opportunities for the industry and patients?

    2025-06-10, 2:15 PM

    Session Details:

    Navigating complexities of managing radioligand therapy oncology trials

    2025-06-10, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Jagtar Dhanda
    Director of Policy Advocacy and Government Affairs, BMS

    Session Details:

    The role of R&D in unlocking economic growth and improving population health

    2025-06-11, 10:00 AM

    View In Agenda
    Next speaker
    Back
    Laura Clifton Hadley
    Associate Director of Clinical Operations, BMS

    Laura Clifton-Hadley is an Associate Director of Clinical Operations based in the UK. She leads all clinical trial and late development activities across the Bristol Myers Squibb portfolio. Laura is an experienced leader, with experience in all phases of trials and therapeutic areas. Prior to BMS, she worked as the head of haematology and brain trials at University College London. She has more than 14 years of clinical operations experience, and more than 12 years of line management experience. She sits on various UK and IE industry bodies/government bodies to promote/facilitate commercial clinical research and to ensure that we are bringing the right studies to the UK and IE.
    Laura received her PhD in microbiology from the University of Reading. She also holds an honours degree in microbiology and virology from the University of Warwick.

    Session Details:

    PANEL DISCUSSION: Current operational challenges in running commercial clinical trials in the UK/IE: the need for increasing our attractiveness globally

    2025-06-11, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Richard Stephens
    Chair, Cancer Research Advocates Forum (CRAF-UK)

    Session Details:

    PANEL DISCUSSION: Patient centricity in oncology trials: where are the opportunities for the industry and patients?

    2025-06-10, 2:15 PM

    Session Details:

    Chairperson’s closing remarks

    2025-06-10, 5:00 PM

    Session Details:

    PANEL DISCUSSION: Exploring the landscape for oncology clinical trials in the UK

    2025-06-10, 10:00 AM

    View In Agenda
    Next speaker
    Back
    Stephen Nabarro
    Head of Clinical Operations and Data Management, Cancer Research UK

    Session Details:

    Reserved for

    2025-06-10, 11:45 AM

    View In Agenda
    Next speaker
    Back
    Alex Churchill
    Deputy Director, Clinical Trials Policy, Department of Health and Social Care

    Session Details:

    KEYNOTE PANEL: Where is the clinical trial industry headed this year and beyond?

    2025-06-10, 10:00 AM

    View In Agenda
    Next speaker
    Back
    Saeeda Bashir
    Head, Clinical Trials Policy and Programmes, Department of Health and Social Care

    Session Details:

    PANEL DISCUSSION: Current operational challenges in running commercial clinical trials in the UK/IE: the need for increasing our attractiveness globally

    2025-06-11, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Emily Pegg
    Associate Vice President, Medical, Northern European Hub, Eli Lilly

    An experienced executive leader within the pharmaceutical industry with a clear focus on and passion for developing high performing cross-functional teams who work without barriers. Highly inclusive yet decisive, adaptable and with a track record of high quality delivery whilst motivating and inspiring the teams around me.

    A GMC registered, NHS trained medical doctor with pharmaceutical industry experience across a broad range of therapeutic areas working with both pre-launch and in-market products in the UK and Europe. Known for being commercially astute and a strong cross-functional worker with 10 years of management experience up to a team size of 120 striving always to create a rewarding, high energy environment for my teams.

    Session Details:

    Navigating the complexities of running clinical trials both home and away: strategies for success

    2025-06-11, 2:00 PM

    Session Details:

    PANEL DISCUSSION: Exploring the landscape for oncology clinical trials in the UK

    2025-06-10, 10:00 AM

    View In Agenda
    Next speaker
    Back
    Victoria Bhui
    Associate Director, Investigator Engagement, Eli Lilly

    Session Details:

    Navigating the complexities of running clinical trials both home and away: strategies for success

    2025-06-11, 2:00 PM

    View In Agenda
    Next speaker
    Back
    Divya Manek
    Director, Clinical Operations, Eyebiotech

    Session Details:

    SPONSOR AND SITE RELATIONSHIPS: Excellence in commercial research delivery: the London North West way

    2025-06-10, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Dr Rebecca Clark
    , Partner, Principal Investigator, Fylde Coast Clinical Research and Co-Clinical Lead, UK Vaccine Innovation Pathway

    Session Details:

    PANEL DISCUSSION: Partnering for innovation: a new model to deliver commercial clinical trials at pace and scale

    2025-06-10, 2:15 PM

    View In Agenda
    Next speaker
    Back
    Catherine Mela
    Head Precision Medicine Operations, GSK

    Session Details:

    Optimising patient consent and data management in a shifting geopolitical landscape

    2025-06-10, 11:45 AM

    View In Agenda
    Next speaker
    Back
    Kerri Fuller
    Director, Resp/Imm/ID PM Operations, GSK

    Session Details:

    ROUNDTABLE SESSIONS

    2025-06-11, 4:00 PM

    Session Details:

    PANEL DISCUSSION: Unravelling the impact of ICH E6 Revision 3: implementing new standards in good clinical practice

    2025-06-10, 4:30 PM

    View In Agenda
    Next speaker
    Back
    Blanka Hezelova
    Associate Director, Precision Medicine Scientific Operations, Bioethics Coach, GSK

    Session Details:

    PANEL DISCUSSION: Leveraging technology and innovation to support clinical trial execution

    2025-06-10, 2:15 PM

    Session Details:

    AI in clinical trials: assessing opportunities and challenges in developing an AI strategy

    2025-06-11, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Dr Janet Messer
    Director of Approvals, HRA

    Experienced strategic leader with extensive experience of operations, business transformation and introducing digital systems. Systems-thinker with focus on delivering cross-sector improvement. Deep knowledge of health and care research regulation and governance.

    Session Details:

    How can we all maximise the efficiency of study set-up?

    2025-06-10, 12:45 PM

    View In Agenda
    Next speaker
    Back
    Rebecca Jackson
    Associate Director, Global Development Systems, Janssen

    Session Details:

    Holding session:

    2025-06-10, 12:45 PM

    View In Agenda
    Next speaker
    Back
    Christiana Dinah
    Director, Research and Development, London North West Healthcare NHS Trust

    Session Details:

    SPONSOR AND SITE RELATIONSHIPS: Excellence in commercial research delivery: the London North West way

    2025-06-10, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Andrea Manfrin
    Deputy Director, Clinical Investigations and Trials, MHRA

    Session Details:

    MHRA: The new outlook of the Clinical Trials Unit

    2025-06-10, 11:45 AM

    View In Agenda
    Next speaker
    Back
    Sarah Tissington
    Regional Director, Clinical Site Management & Monitoring EU/UK, Moderna

    Session Details:

    PANEL DISCUSSION: Partnering for innovation: a new model to deliver commercial clinical trials at pace and scale

    2025-06-10, 2:15 PM

    View In Agenda
    Next speaker
    Back
    Chris Cannaby
    Clinical Operations Manager Lead, MSD

    Session Details:

    PANEL DISCUSSION: Current operational challenges in running commercial clinical trials in the UK/IE: the need for increasing our attractiveness globally

    2025-06-11, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Prof. Lucy Chappell
    Chief Scientific Adviser, Department of Health and Social Care, Chief Executive Officer, National Institute of Health Research (NIHR)

    Professor Lucy Chappell FMedSci is the Chief Scientific Adviser for the Department of Health and Social Care (DHSC), with overall responsibility for the department’s research and development, including the National Institute for Health and Care Research (NIHR), the government’s major funder of clinical, public health, social care and translational research.

    Reporting to the Chief Medical Officer, the Chief Scientific Adviser provides science advice and analysis to ministers across the range of health topics and is involved in cross-government science policy.

    Professor Chappell is Professor of Obstetrics at King’s College London, Honorary Consultant Obstetrician at Guy’s and St Thomas’ NHS Foundation Trust and an NIHR Senior Investigator. She will undertake the Chief Scientific Adviser role on secondment into government, while continuing some of her clinical and academic work.

    DHSC Chief Scientific Adviser

    Responsibilities include:

    • overall responsibility for the Department of Health and Social Care’s (DHSC) research policies and budget, including being head of the National Institute for Health and Care Research (NIHR)
    • supporting analysis and evidenced-based decision-making capacity in the department
    • working with Chief Scientific Advisers across government to maximise the impact of science to benefit the UK population

    Session Details:

    OPENING KEYNOTE: Clinical trials in the UK: a cross sector approach to making the UK a destination for clinical research

    2025-06-10, 9:00 AM

    View In Agenda
    Next speaker
    Back
    Prof Sandip Mitra
    NIHR National Lead for Research in NHS Hospital Setting, Deputy Director for NIHR Health Technology Centre for Long Term Conditions (D4D), National Institute for Health and Care Research (NIHR)

    Innovation-driven clinician and an enterpreneurial enthusiast based at the Manchester Academy of Health Sciences Centre, Manchester University Hospitals. Recognised as an influential health technology leader with major contributions to innovation in healthcare technology, dialysis and delivery systems.

    Passionate about transforming clinical services and patient pathways through enabling technology.

    In various leadership roles as Deputy Director of NIHR MedTech Cooperative Devices for Dignity, Vice Chair for EUDIAL, ERA-EDTA, Chair of the Haemodialysis Study group for UK Kidney Research Consortium. Driving safe and value based health care with national organisations as CQC Speciality Advisor, and as Clinical Reference Group Member for NHS England.

    Managing a diverse portofolio of translational clinical academic research with a global network of collaborators. A trainer, educator and mentor for health professionals at the University of Manchester. Several publications, patents, authored book chapters and media reports of the work in the field.

    Session Details:

    Delivering research in NHS hospitals: the new NIHR Research Delivery Network (RDN)

    2025-06-10, 4:30 PM

    View In Agenda
    Next speaker
    Back
    Maria Koufali
    Head of UK Vaccine Innovation Pathway, National Institute for Health and Care Research (NIHR)

    Session Details:

    PANEL DISCUSSION: Partnering for innovation: a new model to deliver commercial clinical trials at pace and scale

    2025-06-10, 2:15 PM

    View In Agenda
    Next speaker
    Back
    Diane Chisholm
    Head of Clinical Operations, Owkin

    Session Details:

    CASE STUDY: Conducting a Phase 2 oncology trial in the UK

    2025-06-10, 12:45 PM

    Session Details:

    PANEL DISCUSSION: Patient centricity in oncology trials: where are the opportunities for the industry and patients?

    2025-06-10, 2:15 PM

    View In Agenda
    Next speaker
    Back
    Pete Morley
    Clinical Sustainability Manager, Novo Nordisk

    Session Details:

    SUSTAINABILITY SPOTLIGHT: Inspiring partnerships and action in sustainable healthcare

    2025-06-10, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Dr Suki Balendra
    Director, Strategic Partnerships, Paddington Life Sciences and Director, North West London Clinical Trials Alliance

    Suki Balendra a senior leader in the NHS with a 20-year background in facilitating, growing, and promoting health research in the U.K.  She has substantial, in-depth experience across sectors including industry, academia, NHS, and central government.

    She is currently the Director of Strategic Partnerships for Imperial College Healthcare NHS Trust in Northwest London. She leads the strategic work with the Life sciences industry in the region with an emphasis on a new life sciences cluster in Paddington. Suki created and leads the North West London Clinical Trials Alliance. She started her career in the Biotechnology Industry at Abbott Diagnostics Ltd. Within a Good manufacturing practice (GMP) environment she worked on several operational projects to improve efficiency, cost, and reproducibility.

    In 2018 she was seconded to the Office of Life Sciences within the Department of Business and Industrial Strategy. where she attracted and negotiated new business to increase the UK’s market share of health and care research activity. During the pandemic she provided operational leadership to the NHS covid vaccine research response in Northwest London.

    Suki has PhD from the University of Warwick, and she is accredited to black belt in Lean Six Sigma. She is a passionate advocate for UK PLC as the number one destination to conduct clinical trials.

    Session Details:

    Advancing diversity in clinical research

    2025-06-11, 3:30 PM

    View In Agenda
    Next speaker
    Back
    Amelia Hursey
    Strategic Director, Parkinson Europe

    Amelia joined the Parkinson’s Europe  team in Jan 2022 as Research Manager. Since then she has developed Parkinson’s Europe’s Research Strategy, embedding a Research Steering Group into the organisation and helping to increase the presence of Parkinson’s Europe in the clinical research world. She is also focused on bringing new initiatives to the table, such as the Parkinson’s Europe’s Engagement Network, which better connects the Parkinson’s

    community with research across Europe. Parkinson’s Europe is now a partner member of EUPATI and the Critical Path for Parkinson’s as part of this action.

    She has been working in the field of Neurodegenerative research since 2009 and is a Patient Organisations board member with EUPATI since Sept 2023.

    She previously worked for the UK NIHR’s DeNDRoN delivering clinical trials and then at Parkinson’s UK from July 2015 as Research Participation Lead.  She was responsible for initiatives to increase research participation for people affected by Parkinson’s, health care professionals and researchers, and created the innovative Parkinson’s UK Take Part Hub and co-produced the Staying Connected toolkit in collaboration with the HRA UK.

    Session Details:

    Patient involvement and engagement, how well are you doing this?

    2025-06-11, 11:45 AM

    View In Agenda
    Next speaker
    Back
    Maria Lawal
    Patient Advocate

    Session Details:

    PATIENT STORY: Positive and negative experiences in a patient’s cancer journey: how should clinicians and patients work together?

    2025-06-10, 10:45 AM

    View In Agenda
    Next speaker
    Back
    Lara Campana
    Senior Vice President, Research and Translational Science, Resolution Therapeutics

    Session Details:

    CASE STUDY: Challenges and opportunities in cell therapy clinical development outside oncology

    2025-06-11, 11:45 AM

    Session Details:

    PANEL DISCUSSION: Leveraging technology and innovation to support clinical trial execution

    2025-06-10, 2:15 PM

    View In Agenda
    Next speaker
    Back
    Joseph Sutton
    PhD, Biosample Project Leader and Senior Scientist, Roche

    Session Details:

    PANEL DISCUSSION: Leveraging technology and innovation to support clinical trial execution

    2025-06-10, 2:15 PM

    View In Agenda
    Next speaker
    Back
    Marie Lefebvre
    Local Innovation Lead, Sanofi

    Marie Lefebvre is a Local Innovation Lead at Sanofi, specializing in developing and implementing innovative strategies to optimize clinical trials. With a Master's degree in Physiology and Computer Sciences from Poitiers University, Marie brings extensive experience in digital project management and clinical operations to her role. At Sanofi, she leads the development and implementation of the UK Clinical Operation Innovation Road Map, focusing on gap analysis, change management, and the adoption of cutting-edge technologies. Beyond her professional achievements, Marie is passionate about sustainability, serving as a Climate Fresk facilitator and actively participating in various environmental initiatives within the industry.

    Session Details:

    ROUNDTABLE SESSIONS

    2025-06-11, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Karen O’Hanlon
    Chief Development Officer, Stablepharma

    Session Details:

    CASE STUDY: Abbreviated clinical trials: driving innovation and expediting development

    2025-06-10, 4:30 PM

    View In Agenda
    Next speaker
    Back
    Rajinder Sidhu
    Associate Director, Research Governance and Operations, UCLH

    Session Details:

    PANEL DISCUSSION: Current operational challenges in running commercial clinical trials in the UK/IE: the need for increasing our attractiveness globally

    2025-06-11, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Esther Kitto
    Vice President, Clinical Operations, Resolution Therapeutics

    Session Details:

    PANEL DISCUSSION: Current operational challenges in running commercial clinical trials in the UK/IE: the need for increasing our attractiveness globally

    2025-06-11, 2:30 PM

    Session Details:

    KEYNOTE PANEL: Where is the clinical trial industry headed this year and beyond?

    2025-06-10, 10:00 AM

    View In Agenda
    Next speaker
    Back
    Dr Fiona Adshead
    Chair, Sustainable Healthcare Coalition

    Fiona chairs the Sustainable Healthcare Coalition that inspires partnerships and action on sustainable healthcare. She also works as an independent expert advisor and board member for national and global organisations on wellbeing and sustainability.

    She is a high-profile wellbeing and public health leader with a track record of reframing thinking and developing innovative strategy and programmes at the heart of business and government. Her previous roles include Deputy Chief Medical Officer and Director General in the UK Government, Director of Chronic Disease and Health Promotion at the World Health Organisation and Bupa’s Chief Wellbeing Officer.

    Fiona is a visiting Professor at UCL and is a Senior Associate at Cambridge Institute for Sustainability Leadership.  Fiona’s recent board roles include Fresenius ESG Advisory Board, My Green Lab, British Land’s Sustainability Advisory Panel, Marks and Spencer’s Sustainable Retail Advisory Board, and Business in the Community’s Wellbeing Leadership Team. Fiona is a member of the Health System Taskforce of the Sustainable Markets Initiative.

    Session Details:

    SUSTAINABILITY SPOTLIGHT: Inspiring partnerships and action in sustainable healthcare

    2025-06-10, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Vasee Moorthy
    Senior Advisor, R&D, World Health Organization

    Dr. Vasee Moorthy is Senior Advisor, Research for Health Department, WHO Science Division, Geneva, Switzerland. Since 2008, he has held progressively senior roles at WHO in malaria vaccine policy development, Ebola vaccine phase 1-2 trials, global norms in sharing research data and results during public health emergencies, WHO R&D Blueprint for action to prevent epidemics, global consensus on clinical trials policy norms, WHO COVID-19 Research & Innovation Roadmap and the WHO Solidarity Trial of therapeutics supporting clinical trials networks in over 40 Member States in all WHO regions, and most recently, the adoption of resolution (WHA75.8) on clinical trials. Prior to joining WHO, Dr. Moorthy worked as a medical researcher at the University of Oxford, UK (2005-2008); with an NGO, PATH, in USA (2003-2005); running a clinical trials programme at MRC Laboratories in The Gambia (1999-2003), and as a government medical officer in Kwazulu/Natal, South Africa (1996-1997). He received a B.A. and M.A. from the University of Cambridge in Natural Sciences, a B.M.B.Ch medical degree and a Ph.D in malaria immunology and clinical trials both from the University of Oxford.

    Session Details:

    KEYNOTE PRESENTATION: WHO’s clinical trial guidance: what do I need to know

    2025-06-11, 9:00 AM

    View In Agenda
    Next speaker
    Back
    Cameron Keighron
    Project Coordinator, International Diabetes Federation of Europe and Trials@Home consortium member, Patient Advocate

    Session Details:

    ROUNDTABLE SESSIONS

    2025-06-11, 4:00 PM

    View In Agenda
    Next speaker

    Advisory Board

    Select a member to learn more

    Back
    Bao Dinh
    Global Development Business Operation, Takeda

    With over 15 years of experience in Clinical Data Management, Bao leads business strategy and vendor operations for Takeda’s Clinical Data Management, Clinical Data Engineering, and Clinical Data Standards groups, driving organizational growth, managing global FSP partnerships, and enhancing cross-functional collaboration. As a member of the 2024–2025 OCT Advisory Board, Bao brings expertise in clinical outsourcing, strategic vendor partnerships, and RFP process optimization, providing a fresh vision for the organization.

    Beyond professional achievements, Bao is dedicated to fostering collaboration and investing in the local community. As a partner of The Town FC and a Silicon Valley angel investor, Bao champions ventures that advance sustainable growth, youth enrichment, and innovation in technology.’

    Next

    Plan Your Visit

    Venue

    Hilton Park Lane, London, UK

    Accommodation

    Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

    2025 Sponsors

    Select a sponsor to learn more

    FEATURED SPONSORS

    SESSION SPONSORS

    DRINKS RECEPTION SPONSOR

    EXHIBITORS

    co-sponsor

    Why partner?

    Contact us to become a partner

    Partnership Opportunities

    We work with you to design a bespoke package to meet your business needs, where you could:

    • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
    • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
      Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
    • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

    Event reach

    • 200+ attendees each year
    • 80% attendees C-suite level

     

    Take a look at our current sponsors

    Resources

           
           
       

    Media Centre

    Become A Media Partner

    See What It's All About

    Enquiry

    Contact Us

    SPONSORSHIP ENQUIRIES

    Ben Lloyd-Davis

    Head of Healthcare Sponsorship

    +44 207866 9497

    SPEAKING OPPORTUNITIES

    Maya Hudson

    Deputy Head of Production

    +44 204540 7766

    MARKETING ENQUIRIES

    Moona Popal

    Marketing Manager

    DELEGATE ENQUIRIES

    Sunny Saikia

    VIP Delegate Manager

    SPONSORSHIP ENQUIRIES

    To enquire about sponsorship opportunities for the conference, please contact:

    Ben Lloyd-Davis

    Head of Healthcare Sponsorship


    +44 207866 9497

    SPEAKER ENQUIRIES

    To enquire about speaking opportunities for the conference, please contact:

    Maya Hudson

    Deputy Head of Production


    +44 204540 7766